Dr. Carlos Rene Diaz, MD

Dr. Diaz practices at Gastromed in Miami, Florida.

Dr. Diaz's NPI, 1881012557, was assigned on March 31, 2014. Dr. Diaz graduated from Rush Medical College in 2014. Dr. Diaz holds Florida license ME131791.

Dr. Diaz's primary practice is Gastromed, at 9380 Sw 150th St, Miami, FL 33176 in Miami-Dade County. The practice phone is (305) 262-6060.

Dr. Diaz's primary practice is Gastromed in Miami, Florida. Dr. Diaz is also affiliated with Jackson Memorial Hospital. The medical group on file is GastroMed. Dmand AI also links Dr. Diaz to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Diaz practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Diaz's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Diaz is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Diaz is licensed in Florida.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), gastroduodenitis, gastroenteritis, hemorrhoids, intestinal diverticulosis and irritable bowel syndrome (IBS) among the conditions Dr. Diaz treats.

CMS data shows 505 Medicare services from Dr. Diaz across 9 procedure codes in 2024, for 291 Medicare patients. Medicare paid $47,570 for them.

CMS counts 291 Medicare patients who saw Dr. Diaz in 2024. The largest group is 75 to 84, with 95 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 67% are also on Medicaid. Their average risk score is 3.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Diaz's median patient age at 61, with 56% women.

In 2024, Dr. Diaz wrote 1,312 Medicare Part D claims for 443 patients. 73% of them were for generic drugs. CMS names the drug for 1,098 of them, across 20 drugs with 11 or more claims each, at $286,152 in total drug cost. In 2023, CMS named 1,335 claims across 23 drugs.

Dr. Diaz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 34 procedures of colonoscopy by Dr. Diaz, more than 56% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Diaz, published from 2017 to 2019. The most frequent topics are Carcinoma, Hepatocellular and Liver Neoplasms. Dr. Diaz has published most often in Dig Dis Sci. Dr. Diaz's most frequent co-authors are Patricia D. Jones, MD, Paul Martin, MD and Kalyan Ram Bhamidimarri, MD, MPH.

CMS Open Payments shows 385 general payments to Dr. Diaz from 36 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 50% of the total. Bristol-Myers Squibb Company paid the most, $20,425.

Dr. Diaz graduated from Rush Medical College in 2014.

Dr. Diaz is in network with 13 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.